Multi-Antigen Diagnostic for Post-Treatment Lyme Disease Syndrome
Background
Tulane University is actively seeking commercial entities to further develop and commercialize our multi-antigen diagnostic test for post-treatment Lyme disease.
Applications
Used to detect post-treatment Lyme disease syndrome. Improved serodiagnostic test for Lyme disease over the two-tier test and the C6 test. More sensitive and specific than currently available diagnostic tests. Five-antigen multiplex assay. First diagnostic test for post-treatment Lyme disease syndrome
Current Work
This technology has been tested extensively in the laboratory and in mice models.
Inventors
Intellectual Property
US Provisional Patent 62/234,524
Available For
Exclusive License in a Field
Non-exclusive License
Scientific Collaboration
